ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Neuroscience Letters
Volume 375, Issue 3, 3 March 2005, Pages 178-180
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (52 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.neulet.2004.11.009    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2004 Elsevier Ireland Ltd All rights reserved.

No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes

Starlyn Okadaa, Federico M. Farina, Patricia Stapletona, Hanna Viernesa, Sean D. Quigleya, Karen M. Powersa, Terri Smith-Wellera, Gary M. Franklina, b, W.T. Longstrethb, c, Phillip D. Swansonb and Harvey Checkowaya, c, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Environmental and Occupational Health Sciences, University of Washington, Box 357234, Seattle, WA 98195-7234, USA bDepartment of Neurology, University of Washington, Box 357234, Seattle, WA 98195-7234, USA cDepartment of Epidemiology, University of Washington, Box 357234, Seattle, WA 98195-7234, USA

Received 4 October 2004; 
revised 2 November 2004; 
accepted 3 November 2004. 
Available online 1 December 2004.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Reactive oxygen species derived from dopamine metabolism can induce oxidative stress and thus may contribute to Parkinson's disease (PD) pathogenesis. The quinone oxidoreductases, nicotinamide adenine dinucleotide (phosphate) (NAD[P]H): quinone oxidoreductase 1 (NQO1) and dihydronicotinamide riboside (NRH): quinone oxidoreductase 2 (NQO2) detoxify quinones and quinonoid compounds. We investigated associations of genetic polymorphisms of NQO1 (C609T) and NQO2 (I/D, 29 base pairs) with PD in a population-based case-control study of 190 idiopathic PD cases and 305 unrelated controls matched on age and sex. No associations were detected for either gene variant or for any allele combinations.

Keywords: Parkinson's disease; Quinone oxidoreductases; NQO1; NQO2; Genetic polymorphisms

Article Outline

Acknowledgements
References

Neuroscience Letters
Volume 375, Issue 3, 3 March 2005, Pages 178-180
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.